Company: BDRX
Filing Date: 2025-11-24
Form Type: 424B3
Source: 0001214659-25-017135
Chunk: 16

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-11-24
Form: 424B3
Chunk 16
---
us and prior to completion of this offering.           |

| (2) | The selling shareholder                                                                             
 holds (i) warrants issued by us in prior transactions which entitle the selling shareholder         
 to purchase an aggregate of 386,900,000 Ordinary Shares (in the form of Depositary Shares),         
 and (ii) December 2023 Private Placement Pre-Funded Warrants, which entitle the selling shareholder 
 to purchase an aggregate of 81,100,000 Ordinary Shares (in the form of Depositary Shares)           
 and which we are registering hereby. The warrants are subject to a beneficial ownership limitation  
 of 9.99%, which does not permit the selling shareholder to exercise that portion of the warrants    
 that would result in the selling shareholder and its affiliates owning, after exercise, a           
 number of our Ordinary Shares in excess of the beneficial ownership limitation. The amounts         
 and percentages in the table do not give effect to the 9.99% beneficial ownership limitation,       
 if applicable. The principal business address of Bigger Capital Fund, LP is 11700 West Charleston   
 Blvd, #170-659, Las Vegas, NV 89135.                                                                |

| (3) | The                                                                                                
 selling shareholder holds (i) warrants issued by us in prior transactions which entitle the        
 selling shareholder to purchase an aggregate of 393,900,000 Ordinary Shares (in the form           
 of Depositary Shares), and (ii) December 2023 Private Placement Pre-Funded Warrants, which         
 entitle the selling shareholder to purchase an aggregate of 90,600,000 Ordinary Shares (in         
 the form of Depositary Shares) and which we are registering hereby. The warrants are subject       
 to a beneficial ownership limitation of 9.99%, which does not permit the selling shareholder       
 to exercise that portion of the warrants that would result in the selling shareholder and          
 its affiliates owning, after exercise, a number of our Ordinary Shares in excess of the beneficial 
 ownership limitation. The amounts and percentages in the table do not give effect to the           
 9.99% beneficial ownership limitation, if applicable. The principal business address of District   
 2 Capital Fund LP is 14 Wall Street, 2nd Floor, Huntington, NY 11743.                              |

| 13 |

<div align='center'>DESCRIPTION OF OFFERED SECURITIES AND OUR SHARE CAPITAL</div>

The following describes our issued share capital, summarizes the material provisions of our Articles of Association and highlights certain differences in corporate law in the